Division of Translational Pediatric Sarcoma Research @DKFZ
Loading...
Impressive work by @enriquedealava.bsky.social lab on EXO1 in Ewing sarcoma
www.biorxiv.org/content/10.6...
EXO1 Facilitates MiDAS and Prevents Genome Instability and Cell Death in Ewing Sarcoma https://www.biorxiv.org/content/10.64898/2026.06.05.730187v1
USP7 sustains PAX3::FOXO1 enhancer reprogramming and represents a therapeutic vulnerability in Rhabdomyosarcoma https://www.biorxiv.org/content/10.64898/2026.06.03.724934v1
Incredible! Scientists receive a rare standing ovation after announcing that a new treatment can double the survival time for pancreatic cancer, the deadliest cancer which was once considered “undruggable.”
When we fund and support science, we can achieve anything!
(Video: Dr. Wish Dhillon)
Please RT: Opportunity to join us as technician!
We are looking for a technician to support us in our projects in MPN and other myeloid malignancies using epigenomics on primary samples and PDX mouse models.
Where: @carrerasijc.bsky.social
When: Anytime.
What: 👉https://sl1nk.com/0ekf3z6
Video
Very cool preprint by @pablotaboas.bsky.social and team
www.biorxiv.org/content/10.6...
Very happy to have you in the lab, Pablo!
👏Moritz Mall receives Sibylle Assmus Price for neuro-oncology – dotation of 15.000 € – for his project „SAFE-GBM – Decoding the Repressive Architecture that limits Glioblastoma Plasticity“.
@dkfz.bsky.social
Zentralinstitut für Seelische Gesundheit
www.dkfz.de/en/news/pres...
Our work now out @natcomms.nature.com: #PDAC is wired for #necroptosis due to oncogenic #KRAS. @unicologne.bsky.social @cecad.bsky.social @uniklinikkoeln.bsky.social with fantastic collaborators and superstar first author Sofya Tishina!
rdcu.be/foDxS
